HTMC0658
/ Shanghai Huilun
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 16, 2025
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
(clinicaltrials.gov)
- P2 | N=30 | Recruiting | Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
New P2 trial • Immunology • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases • Sinusitis
1 to 1
Of
1
Go to page
1